相关实验视频

Updated: Jun 7, 2025

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells

Published on: July 20, 2016

CD56^briCD38⁺作为慢性髓性白血病中新型中性粒细胞特异性标记物

Panpan Huang^1,2, Cuiping Zhang^1,2, Aimei Zhang^1,2

¹Department of Laboratory Medicine, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, PR China.

|November 19, 2024

概括

增加CD56brightCD38+中性粒细胞的比例有助于诊断慢性髓性白血病 (CML). 这种流动细胞计量标记是高度敏感和特定的CML识别,即使在治疗后.

科学领域:

血液学血液学血液学
免疫型定型免疫型定型
流动细胞计量 (Flow Cytometry) 是一种流动细胞计.

背景情况:

慢性髓性白血病 (CML) 是一种骨髓增殖性瘤.
标准流细胞计缺乏用于CML诊断的特定免疫类型.
在CML患者中,在中性粒细胞上发现了CD56和CD38的异常表达.

研究的目的:

调查CML中性粒细胞中CD56和CD38的异常表达.
通过流细胞计测量来探索这些标记物在识别CML中的诊断价值.

主要方法:

开发一种多参数流细胞计测定方法.
在骨髓核细胞内的CML中性粒细胞中识别异常免疫类型.

主要成果:

在CML患者中观察到CD56brightCD38+中性粒细胞子集的显著增加 (切断值,2.0%).
在学习队列中实现了高特异性 (90.8%) 和敏感性 (84.9%).
这种增加是独立于中性粒细胞数和BCR/ABL1融合,但与爆细胞相关,并通过有效的TKI治疗解决.

结论:

增加的CD56brightCD38+中性粒细胞 (>2.0%) 是CML的敏感和特定的流细胞计标志物.
这种标记可以快速准确地识别慢性髓性白血病.

关键词:

CD38 CD38 CD38 CD38 CD38 CD38 CD38 CD38 CD38 CD38 CD38 CD38 CD38 CD38 CD56 CD56 是一个CD56 CD56 是一个CD56 CD56 慢性骨髓性白血病慢性骨髓性白血病流动细胞计量流动细胞计量免疫型是一种免疫型.

更多相关视频

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

Neutrophil Isolation and Analysis to Determine their Role in Lymphoma Cell Sensitivity to Therapeutic Agents

Neutrophil Isolation and Analysis to Determine their Role in Lymphoma Cell Sensitivity to Therapeutic Agents

Published on: March 25, 2016

相关概念视频